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Abstract
Purpose Type 2 diabetes is a major public health issue particularly in the elderly. Religion may affect the Health Related 
Quality of Life (HRQoL) in such patients, mediated by factors such as religious coping and social support. This study aimed 
to investigate the impact of religiosity on medication adherence and HRQoL.
Methods 793 adults (> 65 years old, 45% females) were recruited from 4 diabetes care centers and followed for 1 year. Duke 
University Religion Index, Spiritual Coping Strategies, Multidimensional Perceived Social Support, Medication Adherence 
Report Scale, WHOQOL-BREF and Diabetes-specific Quality of Life Questionnaire Module were used for assessment, as 
well as HbA1c and fasting blood glucose level. Using structural equation modeling, the potential paths were tested between 
religiosity, medication adherence and HRQoL; social support, religious coping and medication adherence served as the 
mediators.
Results Religious coping and social support were recognized as the significant mediators between religiosity and medica-
tion adherence (CFI = 0.983, TLI = 0.985, and RMSEA = 0.021). The relationships between religiosity and HRQoL were 
considerably mediated by social support, religious coping and medication adherence and these variables explained 12% 
and 33% of variances of generic and specific HRQoL, respectively. There was no significant direct effect of religiosity on 
HRQoL. HbA1c and fasting blood glucose level were successfully loaded on the latent construct of medication adherence 
(factor loading = 0.51 and 0.44, respectively).
Conclusions The impact of religiosity on medication adherence and HRQoL occurs through the mediators such as religious 
coping and social support. Therefore, to improve the adherence to treatment and quality of life, interventions may be designed 
based on these mediators.
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Introduction
Type 2 Diabetes mellitus (T2D) is a chronic disease that 
threatens many elderly people especially those with risk 
factors, such as obesity and sedentary lifestyle [1]. It is 
currently at an epidemic rate worldwide, with currently 
more than 420 million of the world population affected 
by T2D, and this may increase to nearly 600 million in 
2035 [2]. There were more than 20 million people over the 
age of 65 years having T2D in the United States, and in 
developing countries such as China and Malaysia between 
one-third and one-fifth of the elderly have T2D [3–5]. In 
middle-level income countries, the leading cause of death 
can be attributed to uncontrolled blood glucose level for 
both men and women over the age of 50 years [2]. In the 
past two decades, there has been a growing incidence of 
T2D in Iran that may be due to the change of lifestyle to 
unhealthy types. As such, based on a recent report, more 
than 14% of older adults in Iran suffer from this condition 
[6].
There are several irreversible complications associ-
ated with T2D, such as nephropathy, retinopathy, athero-
sclerosis, and diabetic foot that can all negatively affect 
the health-related quality of life (HRQoL) and increase 
the risk of premature mortality in such patients [1]. In 
addition, there have been several studies reporting that 
HRQoL among diabetic patients is considerably lower 
than the general population [7, 8]. However, good adher-
ence to medications may prevent the patients with T2D 
from these complications and improve their HRQoL [9]. 
Indeed, medication adherence (MA) has been recognized 
as the most influential factor in disease management in 
such patients [10]. Unfortunately, at least half of the dia-
betic patients do not take their medications as prescribed 
and a considerable number of patients change the dosage 
of the hypoglycemic agents without guidance from clini-
cians [11]. This problem may be more significant among 
older adults because many of these people (especially 
those in developing countries) are illiterate with insuffi-
cient knowledge or skills of self-care for chronic diseases, 
such as diabetes, or are affected by several physical and 
mental comorbidities that may negatively affect their abili-
ties to manage such conditions.
Overall, none or poor MA may be due to various fac-
tors, such as low level of health knowledge, insufficient 
communication between the patients and healthcare pro-
viders, ignoring cultural differences among the patients 
by the health professionals, side effects of the medica-
tions, and unawareness of the negative outcomes of non-
adherence [12, 13]. However, a number of factors have 
also been identified that may positively impact MA and 
eventually lead to better HRQoL—or in a broader sense, 
quality of life (QoL)—in patients. These factors may have 
mediation roles on MA and identifying them would be 
helpful because health professionals could then consider 
them when attempting to improve MA in patients.
Previous studies have examined the contribution of 
religiosity, religious coping (RC), and spiritual beliefs to 
the management of disease in patients with T2D [14, 15]. 
The relationship between these concepts and outcome 
measures such as diabetic management, coping capability, 
well-being, emotional stress, HRQoL, and glycemic con-
trol have been investigated, and overall positive correlations 
have been found [16–18]. People having religious/spiritual 
beliefs seem to have a better adjustment to their disease and 
acceptable compliance with drug therapy [17]. Moreover, 
they usually show a better mental health status with a lower 
frequency of reporting anxiety or depressive symptoms than 
the atheists [19].
Another factor associated with better MA and self-care 
behaviors among diabetic patients is social support (SS) 
[20]. This factor can improve self-efficacy and self-esteem, 
and provide helpful resources to patients that may positively 
affect their adaptation process and disease management [21]. 
Several authors indicated that social support (SS) is neces-
sary to enable patients towards lifestyle change and adher-
ence to treatment [22]. It is also revealed that patients with 
T2D may seek lower levels of social connections and sup-
ports than healthy people and that may be disruptive to MA 
[23]. In addition, for the elderly who are more dependent on 
family members and relatives than the general population 
due to aging-related disabilities, SS should be considered 
as an important factor that may determine the health status 
among these people.
Despite the important roles of religious coping (RC) and 
SS on MA and HRQoL in patients with T2D, there is lim-
ited literature regarding how these factors may be associated 
with the health outcomes (i.e. MA, QoL and HRQoL); and 
the potential relationships between such factors are unclear. 
Therefore, this study intended to investigate the relationships 
between the factors (RC and SS) and outcomes (MA, QoL 
and HRQoL) and identify the mediation effects of such vari-
ables among older adults.
Methods
The participants
This study was a longitudinal study, conducted in three 
diabetes care centers affiliated with two medical universi-
ties and the Iranian Diabetes Society in Tehran and Qaz-
vin between the years 2015–2017. Convenience sampling 
was used to recruit elderly patients with T2D who attended 
the Outpatient Diabetic Unit of university hospitals and the 
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Iranian Diabetes Society. Inclusion criteria were: a con-
firmed diagnosis of T2D for at least 1 year before the study; 
aged 65 years or older; taking anti-diabetes medications 
regularly, and; agreeing to participate in the study. Patients 
were excluded from the study if they had a severe cognitive 
impairment (i.e. a score in Mini Mental State Examination 
(MMSE) < 19), were not able to read and speak Persian, or 
were not responsible for taking their medications. In total, 
we approached 887 elderly patients with T2D and 43 refused 
to participate and 51 did not meet the inclusion criteria. The 
study was approved by the Human Ethics Committee of 
Qazvin University of Medical Sciences, and all participants 
signed the Informed Consent Form before enrolling in the 
study.
Measures
Religiosity: duke university religion index (DUREL)
This is a brief scale to assess three types of religion-related 
activities including, (1) organizational religious activity or 
frequency of participation in religious events (1 item); (2) 
non-organizational religious activity or individual religious 
activities such as private praying and studying Quran (1 
item), and; (3) intrinsic religiosity that consists of believ-
ing in the God/divine, impact of religious beliefs on one’s 
attitude towards life, and transferring religion into different 
aspects in the life (3 items). For the organizational and non-
organizational religiosity, the frequency of involvement was 
responded to using a Likert scale ranging from 1 (never)—6 
(multiple times a day). In the intrinsic religiosity section, 
the response options ranged from 1 (definitely not true) to 
5 (definitely true). A higher score in the DUREL indicates 
greater religiosity in the three types of religion-related activ-
ities (viz., organizational religious activity [scoring 1–6], 
non-organizational religious activity [scoring 1–6], and 
intrinsic religiosity [scoring 3–15]). Additaionlly, the three 
types of religion-related activities can be combined and a 
total DUREL score can be obtained with the range between 
5 and 27. The Iranian version of the DUREL was shown to 
have acceptable psychometric properties in a previous study 
(Cronbach’s alpha = 0.87–0.92; test–retest reliability using 
the intraclass correlation coefficient [ICC] = 0.62–0.79) [24].
Spiritual coping strategy (SCS) scale
The SCS consists of two sections, RC (9 items) and non-RC 
(11 items). For the purpose of this study, we only used the 
RC section. The items included are related to issues such as 
attending the mosque, receiving religious programs on TV 
or radio, praying individually or in a group, the relationship 
with God or a higher power, trust in God, etc. For all the 
items, the Likert responses range from 0 (never used) to 
3 (often used) that generate a total score ranging between 
0 and 27. The higher the score, the greater use of RC is 
expected. The modified Persian version of SCS in Muslims 
has been found to be a valid and reliable tool (Cronbach’s 
alpha = 0.87; test–retest reliability using the weighted 
kappa = 0.88 [25]).
Multidimensional scale of perceived social support (MSPSS)
Bagherian-Sararoudi et al. established the validity and reli-
ability of the MSPSS in an Iranian population in a previous 
study [26]. This 12-item instrument was used to examine 
the different resources of SS, including family members, 
significant people in one’s life, and friends, with four items 
in each category. All items are rated using a 7-point Lik-
ert scale ranging from 1 (very strongly disagree) to 7 (very 
strongly agree). The total score ranged between 12 and 84. 
A higher score indicates better SS from all resources. The 
psychometric properties of the MSPSS are satisfactory 
(Cronbach’s alpha = 0.84–0.93; test–retest reliability using 
Pearson’s r = 0.74 to 0.84) [26].
Medication adherence (MA)
The Medication Adherence Report Scale with five items 
(MARS-5) was used to assess common non-adherent behav-
iors in the patients. The items are rated using a five-point 
Likert scale from 1 (always) to 5 (never), where a higher 
score indicates a better adherence. The validation of the ver-
sion translated into the Persian language has been confirmed 
in the previous research (Pearson’s r = 0.7 with a medication 
possession rate) [27, 28].
World health organization quality of life scale brief version 
(WHOQOL‑BREF)
This is a self-report measure of QoL that consists of 26 items 
and assesses 4 domains, including physical, psychological, 
social, and environmental aspects of the QoL. Items are 
responded to on a five-point scale from 1 to 5 with higher 
scores in the direction of better QoL. For each domain, the 
total score can range from 0 (worst situation) to 100 (best 
situation). Specifically, the total score is calculated by sum-
ming the item scores (with negatively worded items reverse 
coded), taking the average of the sum, multiplying the aver-
age by 25, and then subtracting 25 from that number. For 
example, if a person has an average item score of 2 in the 
physical domain, the total score for the person’s physical 
QoL is 2 × 25−25 = 25. This questionnaire has shown ade-
quate psychometric properties in Iranian populations (Cron-
bach’s alpha = 0.90; test–retest reliability using Spearman’s 
rho = 0.85 to 0.92) [29].
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Diabetes‑specific quality of life questionnaire module 
(DMQoL)
This instrument has been developed as a diabetes-specific 
measure of HRQoL that may also be used as a supple-
mentary module for WHOQOL-BREF. Ten items with a 
response scale from 1 (very dissatisfied) to 5 (very satis-
fied) are included in the questionnaire. Satisfaction with 
treatment, weight control, physical activity, diet control, 
the management of diabetes-related complications, glyce-
mic control, family relationship, adaptation, the time and 
expenses of diabetes care are assessed. Those who obtain 
a higher score are considered to have better HRQoL. This 
instrument has previously been translated and validated in 
Iran (Cronbach’s alpha = 0.89; test–retest reliability using 
ICC = 0.79 to 0.92) [30].
Mini‑mental state examination (MMSE)
To assess the cognitive function of the participants at the 
recruitment, the MMSE was applied. This is a brief screen-
ing test for cognitive impairment. The maximum score for 
this scale is 30. In our study, those with a score between 24 
and 30 were considered cognitively normal. The culturally 
adapted Persian version of the MMSE was used in the cur-
rent study (Spearman’s rho = 0.46 with the education level 
and − 0.77 with age; sensitivity and specificity using cutoff 
at 23 = 98% and 100%, respectively) [31].
Other measurements
Demographic information on age, gender, education level, 
marital status, accommodation, and smoking history was 
recorded. In addition, information about any diabetes-related 
complications, such as neuropathy and retinopathy, as well 
as the duration of the disease were extracted from the medi-
cal records. Body mass index and blood pressure of the par-
ticipants were measured in the clinics. In addition, biochemi-
cal tests such as fasting blood glucose level, HbA1c, blood 
urea nitrogen, lipid profile, and eGlomerulus Filtration Rate 
(eGFR) were performed.
Procedure
All the patients with T2D who had been referred to the 
Diabetes Units to receive routine care were approached 
to participate in this study. In a short session with the 
research assistants, the study aims were described to the 
patients. The eligibility of the patients was then assessed 
by two physicians, while the participants were asked to 
complete a written Informed Consent Form. Then, the 
baseline measurements including DUREL, SCS, MSPSS, 
and MMSE were performed. Twelve months later, the 
same patients were asked to complete the follow-up meas-
urements including MARS, DMQoL, and WHOQOL-
BREF. An overnight fasting blood sample was also taken 
from each participant.
Data analysis
The data were analyzed using SPSS 23.0 and AMOS 24.0 
software packages. Quantitative data were expressed as 
mean [Standard Deviation (SD)], while categorical vari-
ables were expressed as n (%). To assess the factors associ-
ated with MA and QoL/HRQoL, three models were used. 
In all models, the latent constructs were used to measure 
religiosity (i.e., three dimensions: intrinsic religiosity, 
organizational religious activity, and non-organizational 
religious activity) and MA (i.e., fasting blood glucose 
level, HbA1c level and MARS). Moreover, all the models 
were adjusted for age, gender, duration of the illness, the 
number of comorbidities, MMSE, and education. In the 
first model, the relationship between religiosity and MA 
was examined through RC and perceived SS. In the sec-
ond model, diabetes-specific measurements were added 
to the model to further assess the relationships between 
MA and diabetes-specific HRQoL. In the third model, a 
generic measurement of QoL was replaced with the dia-
betes-specific measurement. The proposed models were 
analyzed using structural equation modeling (SEM) [32]. 
Furthermore, all the models included an interaction effect 
(i.e., RC and SS) on MA. Overall, the number of miss-
ing values was low (ranging from 3.1 to 6.7%). Therefore, 
missing data were estimated by a full information maxi-
mum likelihood method. Moreover, the mediating roles of 
RC, perceived SS, and MA were examined based on the 
four-step Baron and Kenny’s recommendations: in the first 
step, dependent and independent variables were signifi-
cantly related. The independent variable and the mediator 
were significantly related in the second step. The mediator 
and the dependent variable were significantly related in the 
third step. In the final step, the relationship between the 
independent and dependent variable became non-signifi-
cant (full mediation) or became weaker after the addition 
of a mediator (partial mediation) [33].
Several indices of model fit were used: comparative fit 
index (CFI), Tucker–Lewis index (TLI), root mean square 
of error approximation (RMSEA), and standardized root 
mean square residual. Values higher than 0.90 for the 
CFI and TLI indices suggest good model fit. Regarding 
RMSEA and standardized root mean square residual, val-
ues less than 0.08 indicate acceptable model fit [34–36]. 
To ensure that the mediating effect occurs, 5000 bootstrap 
resamples and the 95% bias-corrected confidence esti-
mates were used.
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Results
Among the 793 participants with T2D, 357 (45.0%) 
were females. The average age of the patients was 70.21 
(± 15.10) years. The average years of education were 
4.16 (± 2.11) years. The most common complication was 
hypertension (59.4%), followed by neuropathy (51.7%), 
and ischemic heart disease (38.2%). Around two-thirds of 
the participants (n = 581) lived in the city. The character-
istics of the patients are shown in Table 1.
In terms of model fit, the three proposed models yielded 
acceptable outcomes (Figs. 1, 2, 3); In Model 1, the fit indi-
ces were χ2 (df) = 140.56 (51), CFI = 0.968, TLI = 0.953, 
RMSEA = 0.061, and SRMR = 0.053. In model 2, the fit 
indices were χ2 (df) = 63.12 (58), CFI = 0.983, TLI = 0.970, 
RMSEA = 0.031, and SRMR = 0.025. In the third model, 
the fit indices were χ2 (df) = 145.22 (55), CFI = 0.994, 
TLI = 0.976, RMSEA = 0.059, and SRMR = 0.021. In terms 
of factor loading for the latent constructs, all manifest 
variables were significantly loaded on their correspond-
ent latent structures: intrinsic (factor loadings = 0.64 to 
0.69), organizational (factor loadings = 0.74 to 83), and 
non-organizational religiosity (factor loadings = 0.41 to 
57) loaded on the latent construct of religiosity; MARS-5 
(factor loadings = 0.73 to 0.87), fasting blood glucose level 
(factor loadings = 0.22 to 0.35), and HbA1c level (factor 
loadings = 0.40 to 0.43) loaded on the latent construct of 
MA; physical health (factor loadings = 0.54 to 69), men-
tal health (factor loadings = 0.60 to 73), social relation-
ships (factor loadings = 0.68 to 79), and environment (fac-
tor loading = 0.51 to 66) loaded on the latent construct of 
generic QoL.
Overall, the three models sufficiently explained the 
variance of MA (52.2% for Model 1 and 48.0% for Models 
2 and 3), diabetes-specific HRQoL (59.1%), and generic 
QoL (17.1%). In addition, all paths were significant 
between the study variables in three models except for 
the direct relationship between religiosity and diabetes-
specific HRQoL (standardized beta = − 0.053, p > 0.05) 
and generic QoL (standardized beta = 0.010, p > 0.05).
Table 2 shows the direct, indirect, and total effects 
between SEM variables. In all models RC and perceived 
SS partially mediated the relationships between religi-
osity and MA. In addition, the interaction between RC 
and SS was significantly associated with MA (stand-
ardized beta = 0.401, p < 0.001 for Model 1; standard-
ized beta = 0.663, p < 0.001 for Model 2; standardized 
beta = 0.393, p < 0.001 for Model 3). However, the 
effects of religiosity on both diabetes-specific HRQoL 
and generic QoL were fully mediated by MA, RC and SS 
(Table 2).
Table 1  Participants’ characteristics (n = 793)
Characteristics n (%) or mean (SD)
Baseline
Age (year) 70.21 (15.10)
Gender (male) 436 (55.0%)
Years of education 4.16 (2.11)
Marital status
 Single 68 (8.6%)
 Married 542 (68.3%)
 Widowed 183 (23.1%)
 Current smoker 173 (21.8%)
Accommodation
 Rural 212 (26.7%)
 Urban 581 (73.3%)
Diabetes-related complication
 Hypertension 471 (59.4%)
 Neuropathy 410 (51.7%)
 Nephropathy 291 (36.7%)
 Retinopathy 260 (32.8%)
 Diabetic foot 223 (28.1%)
 Ischemic heart disease 303 (38.2%)
BMI (kg/m2) 27.1 ± 2.9
Systolic blood pressure (mmHg) 147.6 ± 22.1
Diastolic blood pressure (mmHg) 83.6 ± 15.9
Blood creatinine (mg/dl) 1.0 ± 0.4
Blood urea nitrogen (mg/dl) 18.1 ± 7.6
Triglycerides (mg/dl) 142.7 ± 55.4
Total cholesterol (mg/dl) 199.4 ± 44.3
LDL cholesterol (mg/dl) 125.3 ± 59.4
HDL cholesterol (mg/dl) 41.2 ± 28.3
Duration of diabetes (years) 14.3 ± 6.1
eGFR (ml/min per 1.73 m2) 80.3 ± 13.9
MMSE 22.4 ± 4.6
Religiosity
 Intrinsic 9.3 ± 4.9
 Organizational 3.73 ± 1.9
 Non-organizational 4.1 ± 1.9
 Religious coping 20.1 ± 5.4
MSPSS
 Total 59.9 ± 16.7
 Family 21.9 ± 6.8
 Friends 17.2 ± 7.3
 Significant others 20.7 ± 8.3
1 year later
 Medication Adherence Report Scale 12.7 ± 6.8
 Fasting blood glucose level (mg/dl) 148.3 ± 73.2
 HbA1c (%) 7.6 ± 1.9
DMQoL
 WHOQOL-BREF Total score 50.7 ± 5.8
 Physical health 11.1 ± 1.9
 Psychological health 12.4 ± 2.1
 Social relationships 12.8 ± 3.3
 Environment health 14.2 ± 2.0
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Religiosity 
Religious coping  
Social support  
Medication 
adherence 
R2=0.522
Fit indices: 
χ2 (df)=140.56 (51); p<0.01 
Confirmatory fit index=0.968 
Tucker-Lewis index=0.953 
Root mean square error of approximation: 0.061 
Standardized root mean square residual: 0.053 
0.242* 
0.184*ġ
0.142*ġ
0.238*ġ0.182*ġ
Interaction: 
Religious coping 
x Social supportġ
0.401*ġ
Fig. 1  Model 1: Relationships between religiosity, religious coping, 
and medication adherence. Religiosity consists of intrinsic, organi-
zational, and non-organizational religiosity; medication adherence 
includes fasting blood glucose level, HbA1c and Medication Adher-
ence Report Scale Score. Age, gender, duration of the illness, num-
ber of comorbidity and education were adjusted for in the model. 
*p < 0.001
Religiosity 
Religious coping 
Social support  
Medication 
adherence 
2=
Fit indices: χ2 (df)=63.12 (58); p<0.01; 
Confirmatory fit index=0.983 
Tucker-Lewis index=0.970 
Root mean square error of approximation: 0.031 
Standardized root mean square residual: 0.025 
0.264*** 
0.271***
0.261***
0.266***
0.110*** diabetes-specific 
quality of life 
R2=0.591
0.316***
0.064**
0.243***
-0.053 
Interaction: 
Religious coping 
x Social su or
R 0.480
pp t
0.663***
Fig. 2  Model 2: Relationships between religiosity, religious coping, 
medication adherence, and diabetes-specific quality of life. Religios-
ity consists of intrinsic, organizational, and non-organizational religi-
osity; medication adherence included fasting blood glucose level, 
HbA1c and Medication Adherence Report Scale score; the quality of 
life was measured using the diabetes-specific quality of life question-
naire module. Age, gender, duration of illness, number of comorbid-
ity, MMSE and education were adjusted for in the model. *p < 0.05; 
**p < 0.01; ***p < 0.001
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Discussion
In this longitudinal study, we aimed to investigate how 
religiosity may affect disease-specific HRQoL and generic 
QoL and whether factors such as RC, SS, and MA may 
mediate the effects of religiosity on QoL/HRQoL. We 
found that the impact of religiosity on quality of life is 
significantly mediated by our predicted factors (RC, SS, 
and MA) and the direct effects of religiosity on the QoL 
and HRQoL can be considered as unremarkable. There-
fore, all our hypothesized models were consistent with the 
literature that addressed the roles of RC, SS, and MA on 
the QoL. We discovered there may be new types of asso-
ciation between religiosity and quality of life through vari-
ables such as RC, SS, and MA. Additionally, our results 
demonstrated that compared with fasting blood glucose 
level (factor loadings = 0.22 to 0.35), HbA1c (factor load-
ings = 0.40 to 0.43) serves as a stronger biomarker to 
determine the MA for elderly people with T2D.
There are several mediation studies that attempted to 
investigate the potential factors affecting the QoL in dia-
betic patients. Sugiyama et al. examined the effect of a 
self-management empowerment intervention on the mental 
health aspect of HRQoL in African American and Latinos 
with T2D [37]. They aimed to investigate whether this 
intervention has a direct effect, independent of glycemic 
control, SS, and perceived empowerment, on the generic 
HRQoL (assessed by SF-12). In their causal mediation 
analysis, the program indicated a direct effect on HRQoL 
and all the hypothesized factors (i.e., HbA1c, SS, and per-
ceived empowerment) did not show any indirect effects. 
In another study, sleep quality was considered as the 
mediator between depression and anxiety symptoms and 
HRQoL in 86 veterans with diabetes [38]. In this study, the 
mediation effect of sleep quality was confirmed and there 
were significant indirect effects between psychological dis-
tress and QoL for the patients with T2D. The relationship 
between the fear of hypoglycemia and psychological well-
being using the mediation effect of specific HRQoL has 
also been investigated, where significant indirect effects 
were found [38]. However, here we found that other sig-
nificant factors, such as MA, SS, and religiosity may also 
be associated with QoL. These factors have rarely been 
studied previously.
In a systematic review, Jaam et al. assessed the variables 
associated with MA among diabetic patients in two cultur-
ally similar regions (i.e., Middle East and North Africa). 
They found religiosity-related factors to be associated with 
MA in several studies. In addition, they found good social 
interactions may help increase adherence among patients. 
They concluded that cultural components may be considered 
when designing interventions to improve drug adherence in 
Religiosity 
Religious coping 
Social support  
Medication 
adherence 
2=
Generic quality of 
Life R2=0.171
0.010 
Fit indices: χ2 (df)=145.22 (55); p<0.01; 
Confirmatory fit index=0.994 
Tucker-Lewis index=0.976 
Root mean square error of approximation: 0.059 
Standardized root mean square residual: 0.021 
0.242*** 
0.198***
0.192*** 0.169***
0.158***
Interaction: 
Religious coping 
x Social support
0.393***
R 0.480
0.080.142*** 0.251***
Fig. 3  Model 3: Relationships between religiosity, religious coping, 
medication adherence, and generic quality of life. Religiosity con-
sists of intrinsic, organizational, and non-organizational religiosity; 
medication adherence included fasting blood glucose level, HbA1c 
and Medication Adherence Report Scale score; the quality of life was 
measured using the World Health Organization Quality of Life scale 
brief version. Age, gender, duration of illness, number of comorbidity 
and education were adjusted for in the model. *p < 0.05; **p < 0.01; 
***p < 0.001
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this population [13]. In a study performed in Iranian patients 
with T2D, the relationship between HRQoL and spiritual 
well-being was assessed. A positive association between 
the components of HRQoL and spirituality was found, and 
those with higher levels of spiritual well-being showed better 
QoL [16]. These studies are consistent with our findings in 
this study which showed a significant correlation between 
religious beliefs and QoL. However, we also investigated 
novel factors through which religiosity may affect QoL and 
HRQoL. Indeed, we identified that the impact of religiosity 
was mediated by factors, such as RC and SS, both of which 
are part of religious practice. In other words, religiosity is 
a broad concept which exerts its effects on MA, QoL and 
HRQoL via its components, including RC and SS.
However, it needs to be noted that RC and SS are two 
context-based variables and may have different interactions 
with MA, QoL and HRQoL in other cultural and religious 
settings. For example, in a systematic review of the factors 
influencing MA among patients with T2D who were mainly 
from religions other than Islam, Peeters et al. did not report 
any association between religion-related components and 
MA [12]. In the Islamic doctrine, high importance and value 
are placed on health, and any action to threaten good health 
is criticized. As such, non-adherence to medication is not 
accepted by the culture and patients need to try their best to 
restore their health. Additionally, in Islamic religion, there 
is a strong emphasis on helping those who are in need, for-
lorn or disabled. Therefore, when Muslim people are sick, 
they expect their important others, such as parents, offspring, 
relatives and friends, to support them. The important role of 
SS in MA has been confirmed in several studies on patients 
with T2D in other cultures as well; thus it is not strictly 
religion or culture dependent [20, 39].
The current study still had a number of limitations. 
Firstly, our study was a follow-up study without any inter-
vention to investigate the causal mediation effects. Accord-
ing to the hypothesized models, these mediations may exist; 
thus, randomized controlled trials are needed in future 
studies to confirm these models. Second, as mentioned ear-
lier, SS and RC are context-based. Therefore, our findings 
may not apply well to people from other cultures or ethnic 
groups. However, there is some evidence indicating that SS 
and RC may affect variables such as MA and QoL/HRQoL 
(as measured in this study) in older people with chronic dis-
eases [40–43]. Furthermore, as we have found, the asso-
ciation between RC and social SS has been recognized in 
previous studies [44, 45]. Nevertheless, we did not find any 
study that addresses how the interaction between RC and SS 
may affect MA. Our study seems to be the first to invesitigate 
such an interaction in diabetic patients. Third, there may 
be other factors associated with religiosity, such as locus 
of control, spiritual coping, and self-efficacy that we could 
not assess here. Including such factors might improve our 
models and better explain potential mediators. Finally, we 
used a convenience sampling method to recruit participants 
from those who were referred to the Diabetes Care Centers. 
In future studies, the patients with T2D who do not receive 
care from these centers also need to be included.
Conclusion
Religiosity shows both direct and indirect effects on MA. 
However, the effect of religiosity on generic and diabetes-
specific HRQoL is mediated through MA, RC, and SS. Given 
the strong associations between RC and SS with MA, using 
programs to improve MA via developing RC skills and pro-
moting SS may be effective to increase MA among diabetic 
patients. The significant interaction effect between RC and SS 
on MA may also indicate the importance of applying inter-
ventions using RC and SS concurrently. Specifically, patients’ 
adherence to prescribed treatments may be improved when 
healthcare providers simultaneously consider using RC and 
SS. Subsequently, older patients with T2D may have positive 
impacts on both general QoL and disease-specific HRQoL. 
Future studies of this type need to be carried out with patients 
from other cultures and religious backgrounds to investigate 
the broader application of our theory.
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